目的 觀察血塞通注射液聯(lián)合常規(guī)療法治療腦梗死的臨床療效。方法 將122例腦梗死患者隨機(jī)分為治療組（62例）和對照組（60例），兩組均給予常規(guī)綜合治療（胞二磷膽堿靜滴，口服腸溶阿司匹林片、都可喜、維生素等）和對癥支持治療，治療組加用血塞通注射液（主要組分為三七總皂苷）400 mg，每天1次，共治療14 d。結(jié)果 治療組神經(jīng)功能缺損改善優(yōu)于對照組，總有效率達(dá)93.5%，明顯高于對照組（75%）。結(jié)論 血塞通注射液聯(lián)合常規(guī)療法能有效改善腦梗死患者神經(jīng)功能，提高總有效率。

Objective To explore the clinical efficacy of Xuesaitong Injection combined with the conventional treatment in the treatment of cerebral infarction. Methods One hundred and twenty two patients were randomly divieded into treatment (62 patients) and control (60 patients) group, routine combined therapy (Cytidine Diphosphate Choline, enteric coated Aspirin, Duxil, and Vitamins) and support therapy were offered for all patients in both groups, and patients in treatment group received additional Xuesaitong Injection (major component group is Panax notoginseng saponins) 400 mg, once daily for 14 d. Results Neurological function improvement of patients in the treatment was better than that in control group, total effective rates was 93.5% in treatment group, and was significant higher than that in control group (75%). Conclusion Xuesaitong Injection combined with the conventional treatment can effectively improve the neurological function improvement of patients with cerebral infarction and enhance the clinical efficacy.